This session will cover annual billing changes and critical developments currently facing laboratory medicine.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
A newly finalized local coverage determination from MAC Palmetto GBA sets out coverage criteria for two applications of these tests.
Recently introduced bill would require coverage of genomic cancer testing and follow-up screening for certain at-risk individuals.
Senators recently introduced a bill that would require coverage for individuals with a family history of hereditary cancer.